Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT06418061 · RECRUITING
Trial details
- NCT number
- NCT06418061
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-08
- Primary completion
- 2027-06-30
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.